Objective-To examine the effect of an oxidized extracellular oxidation-reduction (redox) state (E h ) on the expression of NADPH oxidases in vascular cells. Methods and Results-The generation of reactive oxygen species by NADPH oxidase (Nox)-based NADPH oxidases activates redox-dependent signaling pathways and contributes to the development of "oxidative stress" in vascular disease. An oxidized plasma redox state is associated with cardiovascular disease in humans; however, the cellular mechanisms by which the extracellular redox state may cause disease are not known. Aortic segments and cultured aortic smooth muscle cells were exposed to E h between Ϫ150 mV (reduced) and 0 mV (oxidized) by altering the concentration of cysteine and its disulfide, cystine, the predominant redox couple in plasma. A more oxidized E h increased the expression of Nox1 and resulted in Nox1-dependent proliferation of smooth muscle cells. Oxidized E h rapidly induced epidermal growth factor receptor phosphorylation via shedding of epidermal growth factor-like ligands from the plasma membrane and caused extracellular signal-regulated kinase 1/2-dependent phosphorylation of the transcription factors activating transcription factor-1 and cAMP-response element-binding protein. Inhibition of epidermal growth factor receptor or extracellular signal-regulated kinase 1/2 activation, or addition of small interference RNA to activating transcription factor-1, prevented the increase in Nox1 expression. Conclusion-Our results identify a novel mechanism by which extracellular oxidative stress increases expression and activity of Nox1 NADPH oxidase and contributes to vascular disease. 
R eactive oxygen species (ROS) contribute to the pathogenesis of cardiovascular diseases, including hypertension, atherosclerosis, cardiac hypertrophy, heart failure, and restenosis. [1] [2] [3] An increase in cellular ROS contributes to the pathogenesis of vascular disease by altering endothelial cell function, enhancing vascular smooth muscle cell (SMC) growth and proliferation, stimulating the expression of proinflammatory genes, and modulating reconstruction of the extracellular matrix. 1, 4 Although an excessive amount of ROS is considered harmful and contributes to the pathogenesis of disease, ROS normally participate in the regulation of important cellular processes, including cell signaling, gene expression, cellular death and senescence, regulation of growth, oxygen sensing, activation of matrix metalloproteinases (MMPs), and angiogenesis. [5] [6] [7] Although several cellular sources of ROS have been identified, the primary source of ROS in vascular cells is NADPH oxidases. 3, 8 Of the Nox isoforms, Nox1, Nox2, Nox4, and Nox5 are expressed in vascular cells, with expression patterns showing cell specificity. For example, only Nox1 and Nox4 are expressed in rodent aortic SMCs. 9 The activity of the vascular NADPH oxidases is regulated by cytokines, hormones, and mechanical forces known to be involved in the pathogenesis of vascular disease. 10, 11 NADPH oxidase expression is associated with the progression of atherosclerosis in humans 12, 13 and with plaque instability in human coronary arteries. 14 Essential cellular processes, such as proliferation, differentiation, and apoptosis, are regulated by reversible oxidation-reduction (redox) reactions of thiol/disulfide couples. [15] [16] [17] The most abundant intracellular low-molecularweight thiol/disulfide couple is glutathione (GSH)/GSH disulfide (GSSG), which regulates a variety of cellular processes. After adjusting for traditional risk factors, the redox state (E h ) of GSH/GSSG was an independent predictor for carotid intima-media thickness in healthy patients. 18 In contrast, the predominant extracellular low-molecular-weight thiol/disulfide couple is cysteine and cystine (Cys/CySS). In humans, the redox state of plasma Cys/CySS differs considerably between individuals, with an oxidized E h Cys/CySS in patients with increasing age, 19 cigarette smoking, 20 and type 2 diabetes mellitus, 17 all of which are risk factors for the development of cardiovascular disease. In addition, levels of oxidized Cys metabolites correlated with endothelial dysfunction in a healthy human population. 21 Recently, oxidized extracellular E h Cys/CySS determined proinflammatory cytokine levels in human plasma. 22 However, the effect of the extracellular redox state on the expression or activity of vascular NADPH oxidases is not known.
The goal of this study was to examine the effect of extracellular oxidative stress (oxidized E h ) on NADPH oxidases in SMCs. Our findings identify a signaling pathway by which oxidation of the extracellular environment activates epidermal growth factor receptor (EGFR) through metalloproteinasemediated shedding of EGF-like ligands, leading to extracellular signal-regulated kinase 1/2 (ERK1/2)-dependent activation of the transcription factor activating transcription factor-1 (ATF-1) and subsequent expression of Nox1. These data identify a novel mechanism by which extracellular oxidative stress activates redox-sensitive pathways that increase Nox1-based NADPH oxidase expression and SMC proliferation.
Methods
The supplemental data (available online at http://atvb.ahajournals. org) provide a complete description of materials and methods used for these studies. Medial SMCs were cultured from thoracic aorta of C57BL/6 mice. 23 The range of extracellular thiol/disulfide redox states (from Ϫ150 to 0 mV) was generated by varying concentrations of Cys and CySS added to cyst(e)ine-free DMEM, as previously described, 24 while maintaining a constant concentration of total Cys moieties of 200 mol/L. Recombinant adenoviruses encoding small interference Nox1 25 and a constitutively active form of the mitogenactivated protein kinase (MAPK) kinase 26 were used. The 21 nucelotide-long siRNA (21-nt) anti-cAMP-response element-binding protein (CREB) and anti-ATF-1 double-stranded small interference RNAs and their scrambled controls were designed using BLOCK-iT RNAi Designer and synthesized by Invitrogen, Carlsbad, Calif. Fluorogenic peptide substrates were used to measure metalloproteinase activity. pGL3 (a luciferase reporter plasmic designed by Promega)-basic (empty vector) or Nox1 promoter-luciferase plasmids 27 were cotransfected into SMCs with plasmid containing SV40 (simian virus) promoter (pSV40)-Renilla control vectors, and data were reported as a ratio between the firefly and Renilla luciferase. Results are expressed as meanϮSEM. Statistical comparisons were performed by Student 2-tailed t tests or ANOVA, with a Dunnett or Tukey multiple comparison posttest as appropriate. PϽ0.05 was considered significant.
Results

Oxidized Extracellular E h Increases Nox1 Expression and SMC Growth
Exposure of isolated aortas to an oxidized extracellular redox environment increased cellular outgrowth and expression of the NADPH oxidase catalytic subunit Nox1 ( Figure 1A ). Because SMCs are the predominant source of Nox1 in the blood vessel, 8 subsequent experiments focused on characterizing the response of cultured SMCs to changes in extracellular redox. Similar to observations in aorta segments, SMC expression of Nox1 increased in response to an increasingly oxidized extracellular redox state. At the oxidized E h of 0 mV, Nox1 mRNA expression increased Ͼ2-fold after 24 hours (supplemental Figure IA) and Ͼ4-fold after 48 hours ( Figure 1B ) compared with the E h of Ϫ150 mV. An increase in Nox1 protein expression was confirmed by Western blotting ( Figure 1C and supplemental Figure IC and D) . In contrast to Nox1, SMC expression of Nox4 was not significantly affected by changes in the extracellular redox state ( Figure 1B and supplemental Figure IB) . Oxidized extracellular E h failed to increase Nox1 levels in human embryonic kidney 293 or human gut epithelial carcinoma cells, identifying cell specificity to this response (supplemental Figure  IE) . Next, we determined whether the oxidized E h -mediated increase in SMC Nox1 resulted in an increase in cellular generation of ROS. Compared with the more reduced extracellular E h , oxidized E h increased superoxide levels in SMCs; this effect was prevented by the selective inhibition of Nox1 expression ( Figure 1D and E). Because Nox1 has been implicated in regulating cell growth, 28 -30 we then examined whether an oxidized E h induced SMC proliferation. Compared with more reduced conditions (Ϫ150 mV), an oxidized E h (0 mV) for 48 hours resulted in Ͼ1.5-fold increase in thymidine incorporation, which was dependent on the expression of Nox1 ( Figure 1F ). These data indicate that exposure of vascular SMCs to an oxidized extracellular environment increases expression and activity of Nox1, resulting in increased levels of ROS and cell proliferation.
Oxidized Extracellular E h Activates EGFR Via MMPs/Disintegrin and Metalloproteinase Family
The EGFR is a primary coordinator of signal transduction from the extracellular environment. 31,32 Therefore, we examined activation of the EGFR as a potential mediator of oxidized extracellular E h -dependent increase in Nox1 gene expression. Oxidized extracellular E h rapidly induced transient EGFR phosphorylation ( Figure 2A and supplemental Figure IIA ), confirmed by the specific inhibitor of EGFR phosphorylation AG1478 (supplemental Figure IIB) . Many ligands of the EGFR are synthesized as transmembrane precursors that must be cleaved by metalloproteinases to release mature ligands. 33 Two closely related metalloproteinase families, MMPs and a disintegrin and metalloproteinase family (ADAMs), contain critical redox-sensitive Cys residues. 34 We tested whether oxidized extracellular E h could activate metalloproteinases, thereby releasing surface-bound EGFR ligands. Rapid phosphorylation of the EGFR in response to oxidized extracellular E h was attenuated by the general metalloproteinase inhibitor GM6001 ( Figure 2B ), confirming involvement of surface metalloproteinases in EGFR activation to oxidative stress, consistent with previous reports. 35 Next, we used the fluorogenic peptide substrates III and IX to investigate the role of specific metalloproteinases in the activation of EGFR. Studies of SMCs exposed to oxidized extracellular E h in the presence of a fluorogenic substrate selective for tumor necrosis factor ␣ converting enzyme (or ADAM17) and related enzymes (eg, ADAM9 and ADAM10) indicated activation of ADAMs within minutes, which per-sisted for several hours ( Figure 2C ). Similarly, studies using a fluorogenic substrate selective for MMPs suggested rapid and sustained activation of these metalloproteinases to oxidize extracellular E h ( Figure 2C ). Additional evidence for MMP activation is provided by the finding that oxidized extracellular E h increased proteolytic activity of MMP-2 and MMP-9 and their proforms ( Figure 2D ). These data indicate that exposure of SMCs to an oxidized extracellular environ- EGFR is phosphorylated by oxidized extracellular E h via activation of metalloproteinases. A, SMCs were treated with E h ϭ0 mV and p-EGFR expression analyzed by Western blotting. Results are normalized to total EGFR expression (nϭ4). B, SMCs were incubated with 20-mol/L GM6001 and then treated with E h ϭ0 mV for 1 minute. Phosphorylated EGFR was analyzed by Western blotting. Results are normalized to total EGFR expression (nϭ4). Blots shown under A and B were run on the same gel but cut for better presentation. C, Fluorogenic peptide substrates were added to E h ϭ0 mV media, then collected at specific points for measurement of metalloproteinase activity. An appropriate blank (without fluorogenic substrate) was subtracted from each measurement (nϭ5). D, Gelatin zymography of MMP activity after control (c) and E h ϭ0 mV (t). A representative gel of 3 independent experiments is shown. Summary data are presented as meanϮSE. *PϽ0.05 vs untreated (0 minutes) and ⌬PϽ0.05 vs 0 mV vehicle. p-indicates phosphorylated form of the protein; pro-MMP, latent form of the MMP. ment activates both the MMP and ADAM families of metalloproteinases, resulting in phosphorylation of the EGFR via shedding of EGF-like ligands from the cell surface. The addition of EGF ligands to SMCs increases intracellular ROS. 36 We examined the effect of short-term changes in extracellular E h on intracellular ROS levels. Forty-five minutes after exposure to 0 mV extracellular Cys/CySS (versus Ϫ150 mV), cellular 5-(and-6)-chloromethyl-2Ј,7Ј-dichlorodihydrofluorescein diacetate (DCFH) fluorescence was increased 43Ϯ9% (nϭ5, PϽ0.05).
Oxidized E h Increases Nox1 Expression Via EGFR
Next, we determined whether phosphorylation of the EGFR was necessary for increasing expression of Nox1 in response to oxidized extracellular E h . Inhibition of EGFR phosphorylation by the specific inhibitor AG1478 prevented the increase in Nox1 expression ( Figure 3A) . Moreover, consistent with our observation that oxidized extracellular E h activates EGFR by metalloproteinase-mediated shedding of EGF-like ligands, the increase in Nox1 expression was abolished by GM6001 ( Figure 3B) . A role for EGFR activation in Nox1 expression is further supported by the observation that AG1478 and GM6001 prevented an increase in Nox1 promoter-luciferase activity ( Figure 3C and D) .
Oxidized Extracellular E h Activates ERK1/2 and Akt
Members of the MAPK family and phosphatidylinositol 3-kinase/Akt are downstream targets of EGFR activation. 31 Therefore, we investigated the involvement of these signaling pathways in mediating an increase in Nox1 expression.
Oxidized extracellular E h activates ERK1/2 and Akt in a time-dependent manner, with maximal phosphorylation within the first several minutes (supplemental Figure IIIA and B), which was abolished by pretreatment with GM6001 ( Figure 4A and D) or with AG1478 ( Figure 4B and E). These data demonstrate that oxidized extracellular E h activates ERK1/2 and Akt through shedding of EGF-like factors and subsequent activation of EGFR. Inhibiting ERK1/2 activation by the selective MAPK/ERK kinase inhibitor U0126 prevented the increase in Nox1 promoter-luciferase activity to oxidized extracellular E h ( Figure 4C ), whereas inhibition of the phosphatidylinositol 3-kinase/Akt pathway by wortmannin had no effect ( Figure 4F) . A role for ERK1/2 in expression of Nox1 was further supported by the observation that expression of a constitutively active form of MAPK/ERK kinase in SMCs markedly increased expression and promoter-luciferase activity of Nox1 (supplemental Figure  IV) . Oxidized extracellular E h had no effect on p38 MAPK (supplemental Figure IIIC) but caused a modest activation of janus kinase (JNK) (supplemental Figure IIID) . However, inhibition of the JNK MAPK pathway with SP600125, a potent JNK inhibitor, had no effect on Nox1 expression and promoter-luciferase activity (data not shown). Together, these results suggest that in response to changes in extracellular redox state, signal transduction from the cell surface to the transcription of Nox1 primarily involves activation of the EGFR-ERK1/2 pathway.
Oxidized Extracellular E h Activates Transcription Factors ATF-1 and CREB
It was previously shown that prostaglandin F 2␣ and plateletderived growth factor (PDGF) increase Nox1 expression via ATF-1. 37 Therefore, we examined the role of ATF-1 and its related transcription factor CREB in oxidized E h -induced Nox1 expression. After extraction of DNA-bound proteins from the nucleus, both CREB and ATF-1 were observed to be phosphorylated by oxidized extracellular E h in a timedependent manner ( Figure 5A ). After construction and testing of small interference RNAs to the transcription factors CREB and ATF-1 (supplemental Figure V) , we found that small interference RNA to ATF-1 prevented the oxidized E hmediated increase in Nox1 expression ( Figure 5B ), whereas small interference RNA to CREB had no effect ( Figure 5C ). Then, we determined if oxidized extracellular E h activated ATF-1 via the EGFR-ERK1/2 signaling pathway. Both GM6001 and AG1478 prevented activation of ATF-1 ( Figure  6A and supplemental Figure VI) ; the same inhibitors failed to significantly prevent activation of CREB ( Figure 6D and supplemental Figure VI) . Similarly, phosphorylation of ATF-1, but not CREB, was inhibited by U0126 ( Figure 6B and E and supplemental Figure VI) . Consistent with our findings that phosphatidylinositol 3-kinase/Akt was not involved in activation of Nox1 expression to oxidized extracellular E h ( Figure 4F ), wortmannin failed to prevent the increase in ATF-1 or CREB phosphorylation ( Figure 6C and F and supplemental Figure VI) . Taken together, these results identify a signaling pathway by which oxidation of the extracellular environment activates EGFR through metalloproteinase-mediated shedding of EGF-like ligands, leading to ERK1/2-dependent activation of the transcription factor ATF-1 and subsequent expression of Nox1 (supplemental Figure VII) .
Discussion
In humans, the redox state (E h ) of plasma Cys/CySS differs considerably between individuals, ranging from approximately Ϫ130 to Ϫ20 mV, with a Cys/CySS redox potential in young healthy individuals estimated at Ϫ80 mV. 38 A more oxidized plasma Cys/CySS is associated with risk factors for the development of vascular disease, including increased age, 19 cigarette smoking, 20 and diabetes. 17 In this study, we describe a signaling pathway in vascular SMCs by which oxidation of extracellular Cys/CySS activates EGFR through metalloproteinase-mediated shedding of EGF-like ligands, leading to ERK1/2-dependent activation of the transcription factor ATF-1 and subsequent expression of Nox1 NADPH oxidase. These findings establish a novel mechanism by which extracellular oxidative stress induces SMC activation and proliferation in vascular disease (supplemental Figure VII) .
The Cys/CySS redox couple represents a nonradical redox system involved in the regulation of cell function. In contrast to the high flux electron transfer pathways of NADH and NADPH, the thiols and disulfides are low flux. Plasma disulfide CySS predicts adverse cardiovascular outcomes. Among markers of oxidative stress, plasma CySS and a more oxidized GSH/GSSG ratio correlated with intima-media thickness. 18 Plasma CySS and mixed disulfide levels were inversely correlated with endothelium-dependent vasodilation in a healthy human population. 21 In addition, oxidized extracellular E h Cys/CySS has been associated with nuclear factor B activation, monocyte binding to endothelial cells, 39 and production of inflammatory cytokines in human plasma. 22 Our study provides a potential cellular mechanism for these findings by showing that an oxidized extracellular redox environment increases Nox1 expression, intracellular ROS, and SMC growth.
Increased expression of NADPH oxidase is associated with development of atherosclerosis 12, 13 and plaque instability in human arteries. 14 Several studies 11,40 -42 have implied Nox1 in the pathogenesis of vascular disease. Nox1 expression and vascular ROS are increased early after balloon injury of rat carotid artery and associated with neointimal hyperplasia. 43 Nox1 has an important role in the migration and proliferation of SMCs 8, 44 and deficiency of Nox1 reduced wire-induced neointima formation by Ͼ50%. 30 In addition, overexpression of Nox1 in SMCs augments angiotensin II-induced hypertension and hypertrophy, 45 and ROS derived from Nox1 reduces bioavailability of NO. 46 Thus, the ability of oxidized extracellular E h Cys/CySS to increase Nox1 expression in SMCs has important clinical relevance in the pathophysiological features of vascular disease.
The effects of an oxidized extracellular environment on NADPH oxidase appear to be cell type and subunit specific. We found that oxidized extracellular E h Cys/CySS increases expression of Nox1 in SMCs while having no effect on the expression of the Nox4 isoform. In addition, an oxidized extracellular E h failed to alter expression of Nox1 in human embryonic kidney 293 and human gut epithelial carcinoma cells, 2 distinctly different cell types, the first having low levels of Nox1 and the second having relatively high levels of Nox1. Although an oxidized E h Cys/CySS increases proliferation of lung fibroblasts 47 and SMCs (present study), human colon carcinoma, human retinal pigment, and NIH 3T3 cells proliferate more rapidly in conditions of reduced extracellular E h Cys/CySS. 24, 48, 49 The explanation for these discordant growth responses among different cell types to changes in extracellular redox potential is not known.
Several cell surface proteins are modified in response to changes in extracellular Cys/CySS redox state by the oxidation of membrane thiols. 39, 49 The activation of intracellular kinases and early mitogenic signaling events involve thiolmediated activation of cell surface proteins. 50, 51 It is proposed that oxidation of critical Cys sulfhydryl motifs in the prodomain of metalloproteinases regulate the activity of the enzyme. 34, 52, 53 Our data confirm the activation of metalloproteinases by an oxidized extracellular E h Cys/CySS with subsequent shedding of EGF-like ligands and phosphorylation of the EGFR. Interestingly, changes in extracellular redox potential are sufficient to activate this mitogenic pathway in the absence of growth factors. Changes in extracellular E h Cys/CySS are not accompanied by changes in intracellular GSH/GSSG redox state and the extracellular Cys/CySS redox state is not regulated by the cellular GSH pool. 24, 48, 54 Previous studies have shown that oxidized extracellular E h Cys/CySS increases intracellular ROS levels in endothelial cells, 39 monocytes, 22 and mouse embryonic fibroblasts. 49 In a recent study, 49 extracellular oxidizing conditions induced mitochondria-derived ROS. We found that Nox1 was responsible for the observed increase in intracellular ROS after exposure of SMCs to oxidized extracellular E h Cys/CySS. These observations are not incompatible and raise the possibility of ROS-induced ROS.
Oxidized extracellular Cys/CySS induced strong activation of the ATF-CREB transcription factors; however, only ATF-1 (not CREB) was necessary for the observed increase in Nox1 expression. This finding is consistent with previous reports 37, 55 showing that upregulation of Nox1 expression was mediated by ATF-1. Transactivation of the EGFR and subsequent activation of ERK1/2 are common events in ATF-1 induction of Nox1 expression by multiple stimuli, including prostaglandin F 2␣ , 56 PDGF, 57 and an oxidized extracellular environment (present study). Despite the presence of both CREB-1 and ATF-1 in vascular SMCs, only ATF-1 was found in the CRE-DNA complexes formed in response to PDGF and thrombin. 58 Similarly, although PDGF and thrombin induced phosphorylation of both CREB and ATF-1, CREB phosphorylation did not contribute to cell growth. 58 Instead, CREB was involved in SMC differentiation and is a negative regulator of SMC growth. 59 CREregulated gene transcription is a complex process involving CREB/ATF-1 binding to the CRE, CREB/ATF-1 phosphorylation, and interaction with coactivator proteins. 59 The regulation of coactivators of CREB/ATF-1 is not well understood and may explain the distinct transcriptional involvement of CREB and ATF-1 in SMCs.
In summary, our findings identify a signaling pathway in vascular SMCs by which oxidation of the extracellular environment activates EGFR through metalloproteinasemediated shedding of EGF-like ligands, leading to ERK1/2-dependent activation of the transcription factor ATF-1 and subsequent expression of Nox1. These data identify a novel mechanism by which extracellular oxidative stress, through oxidation of the Cys/CySS couple, can activate redoxsensitive pathways that stimulate NADPH oxidase expression and vascular SMC proliferation.
